The development of DIC in tumor (AH-109A) inoculated rats with priorly observed plasmin-antiplasmin changes and probable hypercoagulable states
Abe, K.; Endo, E.; Khato, J.
Rinsho Byori. Japanese Journal of Clinical Pathology 25(10): 781-786
1977
ISSN/ISBN: 0047-1860 PMID: 202765 Document Number: 119935
Document emailed within 1 workday
Related Documents
Miyatani, K.; Fukui, I. 1971: Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents Rinsho Byori. Japanese Journal of Clinical Pathology 19(12): 859-862Du, X.H.; Glas-Greenwalt, P.; Kant, K.S.; Allen, C.M.; Hayes, S.; Pollak, V.E. 1985: Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin) Clinical Nephrology 24(4): 186-191
Grabarczyk, E.; Wodyńska, T.; Kotschy, M. 2004: Fibrinolysis parameters: plasmin-alpha2 antiplasmin complexes (PAP) and D-dimers in acute coronary syndromes without ST segment elevation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(102): 555-557
Steplewski, Z.; Vogel, W.H.; Ehya, H.; Poropatich, C.; Smith, J.M. 1985: Effects of restraint stress on inoculated tumor growth and immune response in rats Cancer Research 45(10): 5128-5133
Musatov, M.I.; Zhabin, S.G.; Konenkov, V.I.; Zorin, N.A. 1994: The effect of plasmin and its complexes with alpha 2-macroglobulin and alpha 2-antiplasmin on the proliferative activity of human lymphocytes Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 304-305
Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A. 1979: Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state Folia Haematologica 106(3): 414-425
Páramo, J.A.; Cuesta, B.; Fernández, J.; Alfaro, M.J.; Paloma, M.J.; Rocha, E. 1987: Thrombosis and hypercoagulable states Revista de Medicina de la Universidad de Navarra 31(4): 233-237
Fridrich, L.; Tuchmann, A.; Endler, T.; Meryn, S.; Moritz, E. 1983: Changes in fast antiplasmin (alpha-2-antiplasmin) activity of the plasma of thoracotomized patients Praxis und Klinik der Pneumologie 37 Suppl. 1: 742-744
Besuschio, S.C.; Cavier, M.D.; Corbellini, C.N.; Pereira, J.J.; Carrillo, B.J. 1986: Histopathological changes resembling human immunodepressive conditions observed in sheep inoculated with leucocytes from B.L.V. infected cattle Annales de Pathologie 6(1): 72-73
Gencbay, M.; Turan, F.; Degertekin, M.; Eksi, N.; Mutlu, B.; Unalp, A. 1998: High prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valves Journal of Heart Valve Disease 7(6): 601-609
Fukuda, C.; Iijima, K.; Inoue, N.; Takashima, Y.; Urabe, C.; Nakamura, K. 1988: Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 346-350
Tsuruo, T. 1987: Tumor-induced platelet aggregation and growth-promoting factors as determinants of probable tumor metastasis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 2): 2033-2039
Kobayashi, H.; Shinohara, H.; Takeuchi, K.; Itoh, M.; Fujie, M.; Saitoh, M.; Terao, T. 1994: Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis Cancer Research 54(3): 844-849
Chikahisa, L.; Matsuo, K.; Yamada, Y. 1997: Modulation of tumor cell motility by plasmin Invasion and Metastasis 17(6): 323-333
Madariaga, M.G.; Cachay, E.R.; Zarlenga, D.S. 2007: A probable case of human neurotrichinellosis in the United States American Journal of Tropical Medicine and Hygiene 77(2): 347-349
Takada, A.; Ito, T.; Takada, Y. 1980: Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot Thrombosis and Haemostasis 43(1): 20-23
Kawai, Y.; Watanabe, K. 1989: Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex Rinsho Byori. Japanese Journal of Clinical Pathology 37(3): 248-255
Ichinose, A.; Sakata, Y.; Aoki, N. 1982: Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 178-188
Inman, R.D.; Harpel, P.C. 1986: Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid Journal of Rheumatology 13(3): 535-537
Kawakami, M.; Kitani, A.; Hara, M.; Harigai, M.; Suzuki, K.; Kawaguchi, Y.; Ishii, H.; Kazama, M.; Kawagoe, M.; Nakamura, H. 1992: Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus Journal of Rheumatology 19(11): 1704-1709